Martin Wernli
Martin Wernli publishes mostly in Pulmonary and Respiratory Medicine, Hematology and Oncology, on topics such as Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Lymphoma Diagnosis and Treatment.
- World rank
- #617,076 of 7,710,434 ranked researchers
- Rank in Switzerland
- #11,126 of 80,918
- Works
- 68
- Citations
- 3.5k
- Citations per work
- 51.9
What does Martin Wernli research?
Martin Wernli's work is mostly in Medicine (66%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4566.2%
- Medicine4566.2%
- Everything else2333.8%
- 1Pulmonary and Respiratory Medicine15% of their works
- 2Hematology14% of their works
- 3Oncology14% of their works
- 4Genetics10% of their works
- 5Pathology and Forensic Medicine7% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
Which keywords describe Martin Wernli's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL, Imatinib, Classification and EGFR Mutations.
- Taxanes
- Medical Errors
- Chemotherapy-Induced Peripheral Neuropathy
- Acute Lymphoblastic Leukemia
- Targeted Therapy
- EGFR Mutations
- Imatinib
- Genomic Aberrations
- Rituximab
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Classification
- Lymphoma
- AML
- Acute Myeloid Leukemia
- Childhood Cancer
- Patient Safety Culture
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors293 topics
- Rituximab242 topics
- Chronic Lymphocytic Leukemia151 topic
- Genomic Aberrations151 topic
- BCR-ABL111 topic
- Imatinib111 topic
- Classification91 topic
- EGFR Mutations91 topic
- Lymphoma91 topic
- Targeted Therapy91 topic
- AML71 topic
- Acute Lymphoblastic Leukemia71 topic
- Acute Myeloid Leukemia71 topic
- Chemotherapy-Induced Peripheral Neuropathy71 topic
- Childhood Cancer71 topic
- Medical Errors71 topic
- Patient Safety Culture71 topic
- Taxanes71 topic
Where does Martin Wernli work?
Martin Wernli's main affiliation in the publication record is Kantonsspital Aarau, Switzerland.
How many publications and citations does Martin Wernli have?
OpenAlex counts 68 works and 3,526 citations for Martin Wernli, an h-index of 28, ranking #617,076 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Martin Wernli. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.